Kg&L Capital Management,Llc Bristol Myers Squibb CO Transaction History

Kg&L Capital Management,Llc

$305 Million
Q3 2024

A detailed history of Kg&L Capital Management,Llc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kg&L Capital Management,Llc holds 31,127 shares of BMY stock, worth $1.8 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

31,127

Previous 31,875 2.35%

Holding current value

$1.8 Million

Previous $1.32 Million 21.69%

% of portfolio

0.53%

Previous 0.46%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$39.66 - $51.75 $29,665 - $38,709	-748 Reduced 2.35%	31,127 $1.61 Million
Q2 2024 Jul 22, 2024	SELL	$40.25 - $52.99 $68,626 - $90,347	-1,705 Reduced 5.08%	31,875 $1.32 Million
Q1 2024 Apr 25, 2024	BUY	$47.98 - $54.4 $301,170 - $341,468	6,277 Added 22.99%	33,580 $1.82 Million
Q4 2023 Jan 23, 2024	BUY	$48.48 - $57.85 $277,208 - $330,786	5,718 Added 26.49%	27,303 $1.4 Million
Q3 2023 Oct 19, 2023	SELL	$57.89 - $64.73 $235,091 - $262,868	-4,061 Reduced 15.83%	21,585 $1.25 Million
Q2 2023 Jul 20, 2023	BUY	$63.71 - $70.74 $176,094 - $195,525	2,764 Added 12.08%	25,646 $1.64 Million
Q1 2023 Apr 19, 2023	BUY	$65.71 - $74.53 $700,468 - $794,489	10,660 Added 87.22%	22,882 $1.59 Million
Q4 2022 Jan 18, 2023	BUY	$68.48 - $81.09 $22,392 - $26,516	327 Added 2.75%	12,222 $0
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $752 - $444,673	5,787 Added 94.74%	11,895 $846,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $208,855 - $230,022	-2,876 Reduced 32.01%	6,108 $470,000
Q1 2022 Apr 22, 2022	SELL	$61.48 - $73.72 $2.73 Million - $3.27 Million	-44,362 Reduced 83.16%	8,984 $656,000
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $162,230 - $189,123	-3,025 Reduced 5.37%	53,346 $3.33 Million
Q3 2021 Oct 14, 2021	BUY	$59.17 - $69.31 $926,306 - $1.09 Million	15,655 Added 38.45%	56,371 $3.34 Million
Q2 2021 Jul 15, 2021	BUY	$61.91 - $67.42 $185,172 - $201,653	2,991 Added 7.93%	40,716 $2.72 Million
Q1 2021 Apr 14, 2021	BUY	$59.34 - $66.74 $535,187 - $601,928	9,019 Added 31.42%	37,725 $2.38 Million
Q4 2020 Jan 19, 2021	BUY	$57.74 - $65.43 $309,717 - $350,966	5,364 Added 22.98%	28,706 $1.78 Million
Q3 2020 Oct 13, 2020	BUY	$57.43 - $63.64 $250,681 - $277,788	4,365 Added 23.0%	23,342 $1.41 Million
Q2 2020 Jul 09, 2020	BUY	$54.82 - $64.09 $402,762 - $470,869	7,347 Added 63.17%	18,977 $1.12 Million
Q1 2020 Apr 09, 2020	SELL	$46.4 - $67.43 $14,616 - $21,240	-315 Reduced 2.64%	11,630 $648,000
Q4 2019 Jan 13, 2020	SELL	$49.21 - $64.19 $66,581 - $86,849	-1,353 Reduced 10.17%	11,945 $766,000
Q3 2019 Oct 11, 2019	SELL	$42.77 - $50.71 $162,782 - $193,002	-3,806 Reduced 22.25%	13,298 $674,000
Q2 2019 Jul 15, 2019	BUY	$44.62 - $49.34 $212,435 - $234,907	4,761 Added 38.57%	17,104 $775,000
Q1 2019 May 06, 2019	SELL	$45.12 - $53.8 $265,711 - $316,828	-5,889 Reduced 32.3%	12,343 $589,000
Q4 2018 Mar 28, 2019	BUY	$48.76 - $63.23 $888,992 - $1.15 Million	18,232 New	18,232 $950,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kg&L Capital Management,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Kg&L Capital Management,Llc with notifications on news.

Account

Kg&L Capital Management,Llc Bristol Myers Squibb CO Transaction History